NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Innovate logo
Innovate Biopharmaceuticals, a Raleigh clinical-stage biotechnology company, will partner with a French oncology researcher to find out if gut microbes influence the effectiveness of certain cancer treatments.
WE Pitch logo
The next WE Pitch “Shark Tank”-type event, to help take business development for women entrepreneurs in Central North Carolina to the next level, is scheduled for 6:30 p.m. June 20 at the Carolina Theater in Durham, presented by Central Carolina Women in Business.
Mayne logo
Mayne Pharma, a developer and manufacturer of pharmaceuticals, which opened a new $80 million Greenville facility in 2018, is launching the Mayne Scholarship program at Pitt Community College (PCC) this fall.
BioSpace logo
An article just published on BioSpace.com, a life science industry news and information source, hails North Carolina as a life science “Hotbed,” praising the Research Triangle region’s “whopping” life science growth this century of 108 percent. “The region benefits from an abundance of life sciences talent and a disproportionate amount of NIH funding compared to other regions,” it says
Bioventus logo
Durham-based Bioventus, which develops orthobiologic products, is launching OSTEOAMP SELECT Fibers, an innovative addition to its allograft line of bone graft substitutes for spine, foot & ankle, orthopaedic, and trauma surgeons.
groninger logo
When you get an injection, apply eye drops, swallow cough syrup or apply mascara, there’s a good chance that the product may have been packaged by a machine made by groninger, a German company with a growing U.S. headquarters in Charlotte.
KNOWbio logo
KNOW Bio, LLC, a Durham life science incubator, is merging its gut instinct with the scientific method by pursuing a belief that its nitric oxide-based platform has therapeutic applications for conditions of the gastrointestinal tract.
EDPNC logo
The Economic Development Partnership of North Carolina (EDPNC) is once again registering North Carolina manufacturers for its annual Go Global Road Show, which is being presented April 1-4 in four locations across the state.
Fosh 2.0 logo
Seafood innovators from around the world will converge in North Carolina’s coastal business and recreational magnet of Wilmington April 23 and 24 for the second two-day Fish 2.0, workshop.
bluebird bio logo
bluebird bio, a Massachusetts-based gene and cell therapy company, has opened its first wholly owned manufacturing facility in Durham amid cheers from state leaders.
Exela logo
Lenoir is a small town in the rural foothills, away from the state’s renowned technology hubs. But it's home to Exela Pharma Sciences, a fast-growing manufacturer of generic sterile injectable medications backed by venture capital, government grants and loans, investments by family and friends and personal funds of founder Phanesh Koneru. In its first decade it has grown to 320 employees, and it’s hiring more.
Pairwise logo
Pairwise, one of the Triangle area’s fast-growing agriculture and food biotech companies, has licensed some advanced CRISPR genome editing technologies from two prestigious Boston institutions to expand its crop-editing applications and bring new foods to market.
Fervent logo
Fervent Pharmaceuticals, a clinical-stage drug development company based in Greenville, has announced positive results from its Phase 2A clinical trial of FP-101, a non-hormonal, non-herbal, non-antidepressant treatment of the vasomotor symptoms that accompany menopause.
Verdesian logo
Cary-based agricultural technology company Verdesian Life Sciences' global workforce of 225 strives to advance the company’s goal “to enable a sustainable future for farmers through nutrient use efficiency.”
Aerie logo
Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, has received approval from the U.S. Food and Drug Administration to begin selling Rocklatan, a once-daily eye drop for reducing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension.